YOLFTbeta
Nexgel Inc

Nexgel Inc

NXGL · NASDAQ · Healthcare / Medical Instruments & Supplies

3.88USD+0.09 (+2.37%)

Price History

Full chart

Market Stats

Previous Close3.79
Open3.90
Day Range3.66 – 4.07
52-Week Range0.156 – 2.89
Volume13.64K
Market Cap1.70M
P/E (TTM)0.00
Forward P/E1.38
EPS-0.74
Dividend Yield0.00%
Beta0.75
50-Day Avg0.3691
200-Day Avg0.8132

About

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Brian J. Kieser C.P.A.
  • Employees19
  • Headquarters2150 Cabot Boulevard West, Langhorne, PA, United States, 19047, USA
  • Websitehttps://nexgel.com

Leadership

  • Mr. Brian J. Kieser C.P.A.Interim CEO & Director · b. 1967
  • Mr. Ian Blackman CPAChief Financial Officer · b. 1968
  • Mr. Gregory J. RobbVice President of Operations
  • Mr. Valter PintoManaging Director of KCSA Strategic Communications

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.15M1.99M2.21M717.00K674.00K1.55M2.05M4.09M8.69M11.42M
Growth (%)--7.43%+11.09%-67.60%-6.00%+130.12%+32.04%+99.66%+112.47%+31.46%
Cost of Revenue2.27M1.84M1.70M854.00K965.00K1.54M1.79M3.71M5.94M6.91M
Gross Profit-114.00K147.00K514.00K-137.00K-291.00K8.00K256.00K374.00K2.75M4.51M
Gross Margin-5.30%7.38%23.23%-19.11%-43.18%0.52%12.50%9.15%31.63%39.48%
Operating Expense1.75M1.12M2.40M1.79M1.97M2.58M3.60M3.85M6.30M7.86M
Operating Income-1.86M-969.00K-1.89M-1.92M-2.26M-2.57M-3.35M-3.48M-3.55M-3.35M
Operating Margin-86.62%-48.64%-85.31%-268.34%-335.31%-165.70%-163.48%-85.03%-40.91%-29.35%
EBITDA-1.54M-653.00K-1.57M-1.86M-2.20M-2.17M-3.11M-2.73M-2.90M-2.12M
EBITDA Margin-71.56%-32.78%-70.76%-259.00%-327.00%-140.17%-151.81%-66.76%-33.40%-18.55%
Net Income-1.78M-953.00K-1.89M-1.92M-2.26M-4.31M-4.75M-3.16M-3.28M-3.00M
Net Income Margin-82.53%-47.84%-85.31%-268.20%-335.91%-277.89%-231.74%-77.21%-37.76%-26.27%
R&D----031.00K367.00K103.00K78.00K2.00K
R&D as % of Total Revenue----0.00%2.00%17.92%2.52%0.90%0.02%
Interest Expense-001.00K10.00K2.00M1.34M15.00K81.00K34.00K
Interest Expense % of Total Revenue-0.00%0.00%0.14%1.48%128.82%65.23%0.37%0.93%0.30%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.26M894.00K739.00K1.89M2.26M16.98M10.36M9.96M10.98M10.46M
Total Liabilities467.00K269.00K458.00K1.51M2.19M4.90M2.72M4.79M4.90M5.57M
Total Equity794.00K625.00K281.00K380.00K71.00K12.09M7.64M4.70M5.75M4.46M
Cash---261.00K32.00K13.35M1.10M2.70M1.81M317.00K
Total Debt---917.00K1.28M4.26M2.08M2.80M2.83M3.09M
Net Debt---656.00K1.25M-9.09M982.00K98.00K1.02M2.77M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.32M-777.00K-1.54M-1.81M-1.80M-2.75M-2.99M-3.24M-3.87M-1.31M
Investing Cash Flow--7.00K-312.00K-312.00K-312.00K-269.00K-5.59M4.46M-775.00K-68.00K
Financing Cash Flow1.32M784.00K1.54M2.08M1.88M16.34M-3.66M379.00K3.75M630.00K
Capital Expenditure07.00K312.00K312.00K312.00K269.00K96.00K696.00K443.00K68.00K
Free Cash Flow-1.32M-784.00K-1.54M-1.81M-2.11M-3.02M-3.09M-3.93M-4.31M-1.38M
FCF to OCF100.00%100.90%100.00%100.00%117.32%109.77%103.21%121.51%111.46%105.19%

Earnings

Report DateMay 17, 2021Aug 16, 2021Dec 1, 2021Mar 21, 2022May 13, 2022Aug 10, 2022Nov 8, 2022Mar 27, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 18, 2024May 13, 2024Aug 14, 2024Nov 13, 2024Mar 24, 2025May 13, 2025Aug 12, 2025Nov 12, 2025Mar 30, 2026May 14, 2026Aug 18, 2026Nov 10, 2026
EPS Estimate0.000.00-0.01-0.37-0.15-0.15-0.13-0.15-0.14-0.13-0.12-0.11-0.18-0.14-0.10-0.10-0.10-0.07-0.08-0.03-0.07-0.12-0.24
EPS Actual-0.13-0.15-0.21-0.52-0.28-0.19-0.21-0.11-0.16-0.14-0.11-0.21-0.14-0.15-0.11-0.11-0.09-0.10-0.08-0.15-0.11-0.40-
Surprise---2000.00%-40.54%-86.67%-26.67%-61.54%26.67%-14.29%-7.69%8.33%-90.91%22.22%-7.14%-10.00%-10.00%10.00%-42.86%0.00%-396.00%-57.14%-233.33%-
Timing---After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market-After-hours-Pre-market

Key Statistics & Ratios

Market Cap1.70M
Enterprise Value9.50M
Trailing P/E0.00
Forward P/E1.38
Price / Sales0.14
Price / Book0.51
EPS-0.74
Book Value0.51
Revenue (TTM)12.07M
Gross Profit (TTM)4.23M
EBITDA-4.25M
Profit Margin-51.26%
Operating Margin-67.96%
Return on Equity-115.07%
Return on Assets-18.68%
Shares Outstanding9.75M
Shares Float7.70M
Beta0.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 2.00
  • Buy
    1

Ownership Breakdown

Institutions
13.67%
Insiders
14.02%
Retail / Other
72.31%

Top Institutional Holders

  • Geode Capital Management, LLC
    128.54K1.32%
  • Morgan Stanley - Brokerage Accounts
    54.98K0.56%
  • Renaissance Technologies Corp
    50.96K0.52%
  • Vanguard Capital Management, LLC
    48.92K0.50%
  • Jane Street Group LLC
    42.14K0.43%
  • Vanguard Fiduciary Trust Co
    34.04K0.35%
  • FLAX POND CAPITAL, LLC
    20.00K0.21%
  • XTX Topco Ltd
    17.59K0.18%
  • State Street Corp
    17.26K0.18%
  • HRT FINANCIAL LLC
    15.50K0.16%
  • Hbk Sorce Advisory LLC
    12.50K0.13%
  • Ground Swell Capital, LLC
    11.20K0.11%
  • UBS Group AG
    6.63K0.07%
  • Tower Research Capital LLC
    2.16K0.02%
  • Advisor Group Holdings, Inc.
    3050.00%

Top Fund Holders

  • Fidelity Extended Market Index
    44.56K0.46%
  • Fidelity Total Market Index
    13.58K0.14%
  • Fidelity Series Total Market Index
    8.68K0.09%
  • Fidelity Nasdaq Composite Index
    5460.01%
  • DFA US Micro Cap I
    1980.00%

Stock Splits

  • Oct 12, 20261:20
  • Oct 9, 20261:20
  • Aug 2, 19903:2
  • Nov 16, 19893:2
  • Apr 3, 19893:2